Meningitis is the acute inflammation of the meninges, which can be caused by viruses, bacteria, fungi and parasites. When untreated, the main complications are deafness, epilepsy, cognitive deficit and ultimately death. Ceftriaxone, ampicillin and vancomycin antibiotics are the ones frequently used in the treatment of this disease. However, some of these antibiotics have adverse effects and short half-life. Thus, sustained-release pharmaceutical formulations may prolong the effect, decrease dose and, consequently, avoid undesired effects. Based on the exposed above, this project aims to nanostructure antibiotics for the future treatment of bacterial meningitis. For this purpose, it is proposed to develop formulations and perform the physical-chemical and kinetic characterization of in vitro drug release of these systems. This proposal is part of a more comprehensive project, which will make the biological evaluation of formulations optimized.
News published in Agência FAPESP Newsletter about the scholarship: